Bimatoprost ophthalmic solution in facial vitiligo

BACKGROUND: Vitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes. AIM: To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo. MATERIAL AND METHODS: Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow-up along with dermoscopic (Polarized, 10×) evaluation. RESULTS: Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response. CONCLUSION: Bimatoprost seems to be promising in treating stable vitiligo but large-scale studies are required.